Smallpox virus plaque phenotypes: Genetic, geographical and case fatality relationships

Journal of General Virology

Volumn 90, Issue 4, 2009, Pages 792-798

  Olson, Victoria A ^a   Karem, Kevin L ^a   Smith, Scott K ^a   Hughes, Christine M ^a   Damon, Inger K ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; FATALITY; GEOGRAPHIC ORIGIN; MICROBIAL DIVERSITY; NONHUMAN; PATHOGENICITY; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; SMALLPOX VIRUS; VIRUS CLASSIFICATION; VIRUS ENVELOPE; VIRUS PLAQUE; VIRUS STRAIN; ANIMAL; CELL LINE; EPIDEMIC; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MORTALITY; MOUSE; RABBIT; SMALLPOX; SURVIVAL RATE; VIROLOGY; VIRULENCE; VIRUS CULTURE;

MUS; ORTHOPOXVIRUS; VACCINIA VIRUS; VARIOLA; VARIOLA VIRUS;

VIRUS ENVELOPE PROTEIN;

ANIMALS; CELL LINE; DISEASE OUTBREAKS; HUMANS; MICE; PHENOTYPE; PHYLOGENY; PLAQUE ASSAY; RABBITS; SMALLPOX; SURVIVAL RATE; VARIOLA VIRUS; VIRAL ENVELOPE PROTEINS; VIRULENCE;

EID: 65549132424     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.008169-0     Document Type: Article

References (29)

1. Aldaz-Carroll, L., Whitbeck, J. C., Ponce de Leon, M., Lou, H., Hirao, L., Isaacs, S. N., Moss, B., Eisenberg, R. J. & Cohen, G. H. (2005). Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R. J Virol 79, 6260-6271.
2. Appleyard, G., Hapel, A. J. & Boulter, E. A. (1971). An antigenic difference between intracellular and extracellular rabbitpox virus. J Gen Virol 13, 9-17.
3. Bell, E., Shamim, M., Whitbeck, J. C., Sfyroera, G., Lambris, J. D. & Isaacs, S. N. (2004). Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin. Virology 325, 425-431.
4. Blasco, R. & Moss, B. (1992). Role of cell-associated enveloped vaccinia virus in cell-to-cell spread. J Virol 66, 4170-4179.
5. Davies, D. H., Molina, D. M., Wrammert, J., Miller, J., Hirst, S., Mu, Y., Pablo, J., Unal, B., Nakajima-Sasaki, R. & other authors (2007). Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7, 1678-1686.
6. Engelstad, M. & Smith, G. L. (1993). The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology 194, 627-637.
7. Engelstad, M., Howard, S. T. & Smith, G. L. (1992). A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology 188, 801-810.
8. Esposito, J. J., Sammons, S. A., Frace, A. M., Osborne, J. D., Olsen-Rasmussen, M., Zhang, M., Govil, D., Damon, I. K, Kline, R. & other authors (2006). Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science 313, 807-812.
9. Gurt, I., Abdalrhman, I. & Katz, E. (2006). Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R. Antiviral Res 69, 158-164.
10. Herrero-Martínez, E., Roberts, K. L., Hollinshead, M. & Smith, G. L. (2005). Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J Gen Virol 86, 2961-2968.
11. Katz, E., Wolffe, E. & Moss, B. (2002). Identification of second-site mutations that enhance release and spread of vaccinia virus. J Virol 76, 11637-11644.
12. Katz, E., Ward, B. M., Weisberg, A. S. & Moss, B. (2003). Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein. J Virol 77, 12266-12275.
13. Li, Y., Carroll, D. S., Gardner, S. N., Walsh, M. C., Vitalis, E. A. & Damon, I. K. (2007). On the origin of smallpox: Correlating variola phylogenics with historical smallpox records. Proc Natl Acad Sci U S A 104, 15787-15792.
14. McIntosh, A. A. G. & Smith, G. L. (1996). Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol 70, 272-281.
15. Parkinson, J. E. & Smith, G. L. (1994). Vaccinia virus gene A36R encodes a Mr 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
16. Payne, L. G. (1980). Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J Gen Virol 50, 89-100.
17. Payne, L. G. & Kristensson, K. (1985). Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo. J Gen Virol 66, 643-646.
18. Putz, M. M., Midgley, C. M., Law, M. & Smith, G. L. (2006). Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination. Nat Med 12, 1310-1315.
19. Rotz, L. D., Dotson, D. A., Damon, I. K. & Becher, J. A. (2001). Vaccinia (smallpox) vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 50, 1-25.
20. Sanderson, C. M., Frischknecht, F., Way, M., Hollinshead, M. & Smith, G. L. (1998). Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol 79, 1415-1425.
21. Shida, H. (1986). Variants of vaccinia virus hemagglutinin altered in intracellular transport. Mol Cell Biol 6, 3734-3745.
22. Smith, G. L., Vanderplasschen, A. & Law, M. (2002). The formation and function of extracellular enveloped vaccinia virus. J Gen Virol 83, 2915-2931.
23. Stanford, M. M., McFadden, G., Karupiah, G. & Chaudhri, G. (2007). Immunopathogenesis of poxvirus infections: Forecasting the impending storm. Immunol Cell Biol 85, 93-102.
24. Trindade, G. S., Emerson, G. L., Carroll, D. S., Kroon, E. G. & Damon, I. K. (2007). Brazilian vaccinia viruses and their origins. Emerg Infect Dis 13, 965-972.
25. Vanderplasschen, A., Mathew, E., Hollinshead, M., Sim, R. B. & Smith, G. L. (1998). Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A 95, 7544-7549.
26. van Eijl, H., Hollinshead, M., Rodger, G., Zhang, W. H. & Smith, G. L. (2002). The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol 83, 195-207.
27. Wolffe, E. J., Isaacs, S. N. & Moss, B. (1993). Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J Virol 67, 4732-4741.
28. Yang, H., Kim, S. K., Kim, M., Reche, P. A., Morehead, T. J., Damon, I. K., Welsh, R. M. & Reinherz, E. L. (2005). Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. J Clin Invest 115, 379-387.
29. Zhang, W. H., Wilcock, D. & Smith, G. L. (2000). Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol 74, 11654-11662.